Geneos Wealth Management’s Commault Systems CVLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-151
Closed -$26.3K 2650
2025
Q2
$26.3K Sell
151
-174
-54% -$29.7K ﹤0.01% 1903
2025
Q1
$51.3K Buy
325
+304
+1,448% +$50K ﹤0.01% 1916
2024
Q4
$3.17K Sell
21
-4
-16% -$644 ﹤0.01% 2473
2024
Q3
$3.85K Buy
+25
New +$3.52K ﹤0.01% 2142
2021
Q4
Sell
-175
Closed -$13K 2788
2021
Q3
$13K Hold
175
﹤0.01% 2105
2021
Q2
$13K Hold
175
﹤0.01% 2093
2021
Q1
$12K Hold
175
﹤0.01% 2289
2020
Q4
$11K Buy
+175
New +$8.18K ﹤0.01% 2173

Other funds holding CVLT

Geneos Wealth Management's CVLT Position: Q3 2025 in Review

Geneos Wealth Management sold out of Commault Systems (CVLT) in Q3 2025, closing a stake of 151 shares — an estimated $26.3K sold.

Geneos Wealth Management first reported a position in CVLT in Q4 2020 and held it in 8 quarters. The position peaked at $51.3K in Q1 2025. 446 funds tracked by Wall St. Rank hold CVLT as of Q3 2025.

  • Geneos Wealth Management reported no remaining Commault Systems position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 151 Commault Systems shares in Q3 2025, an estimated $26.3K.
  • Geneos Wealth Management first reported a position in Commault Systems in Q4 2020 and held it in 8 quarters.
  • Geneos Wealth Management's Commault Systems position peaked at $51.3K in Q1 2025.
  • 446 funds tracked by Wall St. Rank held Commault Systems as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.